Patient Counseling Archives - American College of Apothecaries

ACA WEBINAR: Methylene Blue and Clinical Opportunities

Wednesday, November 19, 2025
1:00 pm EASTERN / 12:00 pm CENTRAL / 11:00 am MOUNTAIN / 10:00 am PACIFIC

Curious about the latest research and clinical uses of Methylene Blue? This upcoming program will explore its emerging role in treating conditions like Lyme disease, dementia, Alzheimer’s, post-COVID syndrome, and more—plus offer practical compounding tips for pharmacy teams.

Registration isn’t open yet, and this activity is not yet accredited—but if you want to be the first to get updates and know when registration goes live, sign up for notifications today!

This talk aims to illuminate the evolving landscape of Methylene Blue’s applications in healthcare, specifically focusing on its novelutilization for enhancing patient outcomes. Delving into recent advancements and promising research for specific conditions such as Lyme disease, dementia, bladder health, Alzheimer’s disease, post-COVID syndrome, and for anti-aging /nootropic effects.

The program will also cover Methylene Blue’s pharmacology, including mechanisms of action, pharmacokinetics, and pharmacodynamics, helping learners describe these key concepts in detail. In addition, participants will outline evidence-based prescribing protocols and dosing strategies for Methylene Blue in clinical practice. They will learn to recognize common adverse reactions and explain appropriate management strategies to ensure patient safety.

Pharmacists can expect to gain insights into how this versatile compound is contributing to improved patient care, paving theway for a more nuanced understanding of its potential impact on healthcare outcomes. Included with be practical compounding pharmacy process tips that will benefit Pharmacy Technicians and improve lab efficiency.

ACA Members $40; Non-Members $50
SPECIAL PRICING FOR PHARMACY TECHNICIANS AND STUDENT PHARMACISTS

Whether you’re interested in understanding the science behind Methylene Blue or want to stay current on new clinical opportunities, this session offers timely insight for pharmacists and pharmacy technicians. Join the notification list below and be the first to know when registration opens!

Loading…

ACA WEBINAR: MEN AND COVID SEVERITY – New Research that Links Them … What Are the Implications?

Taisha Cunningham2025-06-19T13:33:10-05:00June 19th, 2025|Categories: Clinical Research, Continuing Education, COVID-19, Endocrinology, Hormones, Infectious Diseases, Men's Health, Patient Counseling, Pharmacology, Public/Community Health|Tags: ACA Fellows, ACA members, news, Pharmacists, Pharmacy Technicians, Student Pharmacists|

Earn 1.0 hour (0.1 CEUs) of continuing education credit when you purchase the webinar, MEN AND COVID SEVERITY – New Research that Links Them … What Are the Implications?

This activity explores recent research highlighting the hormonal differences that may contribute to why men experienced more severe outcomes from COVID-19 compared to women. Participants will examine the role of testosterone in immune response and how its levels—and conversion to other hormones like estradiol—may have influenced COVID-19 severity in male patients. The session will also address how this hormonal imbalance might relate to other acute viral illnesses beyond COVID-19, offering broader clinical insight.

In addition, the activity will cover current evidence on testosterone therapy and its impact on cardiovascular health and prostate cancer risk, including discussion of ongoing large-scale studies such as the TRAVERSE trial. Participants will review the physiological role of dihydrotestosterone (DHT), testosterone’s more potent metabolite, and how understanding these hormonal mechanisms can help guide discussions around men’s health.

By the end of the activity, pharmacists and pharmacy technicians will be better equipped to evaluate emerging literature, understand the implications of hormone-related research, and communicate effectively with both patients and healthcare providers. This knowledge will enhance their ability to engage in meaningful conversations about hormone therapy, risks and benefits, and personalized care approaches related to testosterone and viral disease outcomes.

CLICK HERE TO VIEW FULL ACTIVITY DESCRIPTION

Whether you’re interested in understanding the science behind COVID-19 severity in men or want to stay current on hormone-related health risks, this session offers timely, research-based insight for pharmacists and pharmacy technicians. Registration is below.

The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 1 contact hour (0.1 CEUs) of continuing education credit for pharmacists and pharmacy technicians.

navigation

affiliates

connect

refer a colleague